TAOX earnings analysis
What we found in TAOX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted 10-Q text does not include the statements of operations, balance sheets, cash flows, or MD&A metrics, so revenue, margins, EPS, liquidity, and free cash flow cannot be assessed. The principal disclosed development is that controls remained ineffective as of June 30, 2026, with weaknesses spanning segregation of duties, financial reporting, and IT controls. Management reported no material changes to the 2025 Form 10-K risk factors and provided no quantitative guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Control weaknesses remain material
- Management concluded that disclosure controls and procedures were ineffective as of June 30, 2026, citing weaknesses in payroll and banking segregation of duties, period-end reporting, and IT general controls.
- Management affirms financial statement presentation
- The company stated that its financial statements and other information for the periods presented fairly present its financial condition, results of operations, and cash flows in all material respects, notwithstanding the control weaknesses identified as of June 30, 2026.
- Equity issued for investor relations
- The company issued 22,563 common shares to IRTH Communications on January 16, 2026, and 1,025 and 1,181 shares to Neil Cataldi on March 6 and June 8, 2026, respectively, in exchange for investor-relations services.
- No insider trading-plan changes
- No directors or executive officers adopted, modified, or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter ended June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Ineffective disclosure controls
- Disclosure controls were ineffective as of June 30, 2026, due to inadequate segregation of duties, ineffective period-end financial reporting processes, and ineffective IT general controls. Management also said these weaknesses may affect its ability to determine whether errors or inappropriate actions occurred.
- Unresolved internal-control weakness
- Management previously concluded that internal controls were not effective during the fiscal year ended December 31, 2025, because they failed to detect inappropriate application of U.S. GAAP; the issue remains unresolved as of June 30, 2026.
- No new risk-factor update
- The filing reports no material changes from the risk factors disclosed in the Form 10-K for the fiscal year ended December 31, 2025. Accordingly, the existing cryptocurrency, operating-cost, and regulatory risks identified in that 10-K remain applicable, with no new quantified risk-factor update in this 10-Q.
What they said about what is next.
No quantitative revenue or EPS outlook was provided in the extracted 10-Q text; the filing does not provide guidance fields.
The filing reads worse than the one before it.
What came before.
- 10-K · June 5, 2026
- TAO Synergies Inc. demonstrated significant growth in its transition to a cryptocurrency-focused business model, reporting revenue from TAO staking of $299,061 in 2025 and net losses of $29,075,807. The company has made…
- 10-Q · May 13, 2026
- TAO Synergies reported significant revenue growth from its pivot to cryptocurrency, with operating revenue reaching $388,774 in Q1 2026, a stark contrast to zero revenue in Q1 2025. The company registered a net income…
- 10-K · March 31, 2026
- TAO Synergies (formerly Synaptogenix) completed a rapid strategic pivot in 2025 from a pure-play biopharmaceutical developer of Bryostatin-1 to a cryptocurrency treasury operator focused on accumulating and staking the…
- 10-Q · November 14, 2025
- TAO Synergies reported its first staking revenue of $203,371 for Q3 2025 and a narrower GAAP loss (net loss attributable to common stockholders) of $3,968,457 (basic loss per share $1.56) versus a larger loss in Q3…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TAOX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever